Literature DB >> 2023205

Superior vena cava occlusion in a patient with antiphospholipid antibody syndrome.

Y Tomer1, A Kessler, A Eyal, A Many, Y Shoenfeld.   

Abstract

A 55-year-old woman with a lupus like disease, associated with the lupus anticoagulant, was admitted because of facial edema. Her facial swelling was previously attributed to the steroids she had been taking and they were tapered without improvement. Laboratory tests revealed high titers of anticardiolipin antibodies. Computerized tomography of her chest and Doppler ultrasound examination of her neck veins demonstrated a thrombus in the superior vena cava. She was treated with heparin and was maintained with longterm warfarin therapy with uneventful followup. Superior vena cava obstruction should be added to the long list of thromboembolic complications of the antiphospholipid syndrome.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2023205

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  3 in total

1.  Systemic vasculitis associated with seronegative spondylarthropathy (Reiter's syndrome).

Authors:  U Boehni; B Christen; P Greminger; B A Michel
Journal:  Clin Rheumatol       Date:  1997-11       Impact factor: 2.980

2.  Lupus anticoagulant, factor V Leiden, and methylenetetrahydrofolate reductase gene mutation in a lupus patient with cerebral venous thrombosis.

Authors:  Imad Uthman; Ismail Khalil; Raja Sawaya; Ali Taher
Journal:  Clin Rheumatol       Date:  2004-04-14       Impact factor: 2.980

3.  Pathogenic natural anti-cardiolipin antibodies: the experience from monoclonal gammopathy.

Authors:  J Cohen; R Bakimer; M Blank; G Valesini; Y Shoenfeld
Journal:  Clin Exp Immunol       Date:  1994-08       Impact factor: 4.330

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.